menu
    • menu

    Company profile for Genenta Science

    NEW Drugs in Dev: 1
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We develop a gene transfer strategy into hematopoietic cells to target specific anti-tumor proteins. A definite vector delivers the gene into the cells. We use a combination of transcriptional and mediated control gene expression to selectively direct the anti-tumor proteins to the tumor area. Based on our exclusive mechanism, the immune system cells are reactivated and armed with a potent drug. Genenta has obtained regulatory...
    We develop a gene transfer strategy into hematopoietic cells to target specific anti-tumor proteins. A definite vector delivers the gene into the cells. We use a combination of transcriptional and mediated control gene expression to selectively direct the anti-tumor proteins to the tumor area. Based on our exclusive mechanism, the immune system cells are reactivated and armed with a potent drug. Genenta has obtained regulatory approvals to initiate Phase I/II clinical trials in Multiple Myeloma patients with early relapse after front line therapy and newly diagnosed Glioblastoma Multiforme patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Genenta ScienceItaly Flag
    Country
    Country
    Italy
    Address
    Address
    Via Olgettina 58 20132 Milano
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.genenta.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/genenta
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Italian Government Appoints Genenta CEO to Academy Board
    Italian Government Appoints Genenta CEO to Academy Board

    13 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/13/3255290/0/en/Genenta-Evolving-into-Saentra-Forge-Announces-CEO-s-Appointment-by-the-Italian-Government-to-the-Board-of-Guarantors-of-the-Italian-Academy-at-Columbia-University.html

    GLOBENEWSWIRE
    13 Mar 2026
    Share Share
    Genenta Advances Saentra Forge, Strengthens ATC and Expands
    Genenta Advances Saentra Forge, Strengthens ATC and Expands

    27 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/27/3246321/0/en/Genenta-Advances-Transformation-into-Saentra-Forge-Strengthens-ATC-Governance-and-Expands-Strategic-Industrial-Consolidation-Platform.html

    GLOBENEWSWIRE
    27 Feb 2026
    Share Share
    Genenta Transforms Into Biotech And Defense Industry Consolidator
    Genenta Transforms Into Biotech And Defense Industry Consolidator

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226097/0/en/Genenta-Announces-Strategic-Transformation-into-a-Biotech-Defense-Aerospace-and-National-Security-Industrial-Consolidator.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    Genenta Science Provides Update On CEO Ownership
    Genenta Science Provides Update On CEO Ownership

    19 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/19/3208308/0/en/Genenta-Science-Provides-Update-on-CEO-Ownership.html

    GLOBENEWSWIRE
    19 Dec 2025
    Share Share
    Genenta Shows Long-Term Survival Trends In GBM Trial
    Genenta Shows Long-Term Survival Trends In GBM Trial

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193229/0/en/Genenta-Reports-Long-Term-Survival-Trends-and-Immune-Findings-in-Brain-Tumor-GBM-Trial.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Genenta Prices $15M Direct Offering Of ADS Share
    Genenta Prices $15M Direct Offering Of ADS Share

    26 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/27/3174282/0/en/Genenta-Announces-Pricing-of-15-0-Million-Registered-Direct-Offering-of-American-Depositary-Shares.html

    GLOBENEWSWIRE
    26 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search